We invested in Wavely Diagnostics because it addresses a clear access problem in pediatrics with a more distributed and practical diagnostic model. We like businesses that improve decision-making earlier in the care journey, especially when they can reduce avoidable utilization and make clinically useful information easier to obtain. Wavely fits that pattern well. The company also reflects a larger Totipotent theme around diagnostics that are operationally lightweight and easier to bring closer to the patient. In a healthcare system where convenience, early intervention, and workflow fit matter more than ever, Wavely represents the kind of innovation that can create value through both access and usability.